Moderna Says Existing COVID Vaccine Booster Appears Effective Against Omicron – Higher Dose Performs Even Better 20/12/2021 Elaine Ruth Fletcher In what should be reassuring news for health systems the world over, preliminary lab results suggest that Moderna’s authorised COVID booster dose of 50 µg offers 37-fold more protection against Omicron than the first two vaccine jabs after 29 days. And a 100 µg booster -comparable to the dose received in the first two shots […] Continue reading -> Still A Long Way To Go Until Everyone Is Safe From COVID – and Vaccine Numbers Don’t Tell The Whole Story 17/12/2021 Riccardo Lampariello As more vaccine supplies finally become available to the world’s low-and middle-income countries (LMICs), the latent challenges that should have been addressed long before have emerged. Those include vaccine hesitancy and the ability of weak health systems to mount mass vaccination campaigns amidst other pressing health needs. Global policymakers need to shift their attention from […] Continue reading -> South Africa’s mRNA Vaccine Hub Aims for Clinical Trial by 2023 and ‘Won’t Violate Patents’ 13/12/2021 Kerry Cullinan CAPE TOWN – The mRNA vaccine ‘hub’ being set up in South Africa aims to have a COVID-19 vaccine candidate ready for clinical trials by 2023. Meanwhile, the World Health Organization (WHO) – which initiated the South Africa hub to address regional inequity – is setting up a “biomanufacturing workforce training centre” to address the […] Continue reading -> Virus Reproduction Number in South Africa’s Omicron Epicentre is ‘Something We Have Never Seen’ 10/12/2021 Kerry Cullinan The virus reproduction number of the Omicron variant in Gauteng province – the epicentre of South Africa’s pandemic – is 3 – meaning that one infected person will infect three others on average. That is the highest seen so far in the country’s COVID-19 pandemic history – and testimony to the highly infectious nature of […] Continue reading -> World Health Assembly Appears Set to Move Ahead on Pandemic Treaty Negotiations – With Very Different Views About Outcomes 29/11/2021 Elaine Ruth Fletcher In a first face-to-face meeting in Geneva since the start of the COVID-19 pandemic, the World Health Organization’s 194 member states appeared set to adopt a landmark decision to negotiate a new treaty or framework convention governing pandemic response, dubbed “Our World Together”, and with over 100 countries now declaring co-sponsorship. But from the start […] Continue reading -> Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> ‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Independent Panel Co-Chairs Blast Slow Pace of Pandemic Reforms – Call for UN Summit After Next Week’s Special World Health Assembly 22/11/2021 Elaine Ruth Fletcher Six months after publication of their landmark report, Make it the Last Pandemic, the co-chairs of Independent Panel have re-entered the political fray over the slow pace of urgently needed reforms to vaccine equity, pandemic finance and countries’ legal obligations – that they say are required to end the COVID-19 pandemic and head off the […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> Posts navigation Older postsNewer posts
Still A Long Way To Go Until Everyone Is Safe From COVID – and Vaccine Numbers Don’t Tell The Whole Story 17/12/2021 Riccardo Lampariello As more vaccine supplies finally become available to the world’s low-and middle-income countries (LMICs), the latent challenges that should have been addressed long before have emerged. Those include vaccine hesitancy and the ability of weak health systems to mount mass vaccination campaigns amidst other pressing health needs. Global policymakers need to shift their attention from […] Continue reading -> South Africa’s mRNA Vaccine Hub Aims for Clinical Trial by 2023 and ‘Won’t Violate Patents’ 13/12/2021 Kerry Cullinan CAPE TOWN – The mRNA vaccine ‘hub’ being set up in South Africa aims to have a COVID-19 vaccine candidate ready for clinical trials by 2023. Meanwhile, the World Health Organization (WHO) – which initiated the South Africa hub to address regional inequity – is setting up a “biomanufacturing workforce training centre” to address the […] Continue reading -> Virus Reproduction Number in South Africa’s Omicron Epicentre is ‘Something We Have Never Seen’ 10/12/2021 Kerry Cullinan The virus reproduction number of the Omicron variant in Gauteng province – the epicentre of South Africa’s pandemic – is 3 – meaning that one infected person will infect three others on average. That is the highest seen so far in the country’s COVID-19 pandemic history – and testimony to the highly infectious nature of […] Continue reading -> World Health Assembly Appears Set to Move Ahead on Pandemic Treaty Negotiations – With Very Different Views About Outcomes 29/11/2021 Elaine Ruth Fletcher In a first face-to-face meeting in Geneva since the start of the COVID-19 pandemic, the World Health Organization’s 194 member states appeared set to adopt a landmark decision to negotiate a new treaty or framework convention governing pandemic response, dubbed “Our World Together”, and with over 100 countries now declaring co-sponsorship. But from the start […] Continue reading -> Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> ‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Independent Panel Co-Chairs Blast Slow Pace of Pandemic Reforms – Call for UN Summit After Next Week’s Special World Health Assembly 22/11/2021 Elaine Ruth Fletcher Six months after publication of their landmark report, Make it the Last Pandemic, the co-chairs of Independent Panel have re-entered the political fray over the slow pace of urgently needed reforms to vaccine equity, pandemic finance and countries’ legal obligations – that they say are required to end the COVID-19 pandemic and head off the […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> Posts navigation Older postsNewer posts
South Africa’s mRNA Vaccine Hub Aims for Clinical Trial by 2023 and ‘Won’t Violate Patents’ 13/12/2021 Kerry Cullinan CAPE TOWN – The mRNA vaccine ‘hub’ being set up in South Africa aims to have a COVID-19 vaccine candidate ready for clinical trials by 2023. Meanwhile, the World Health Organization (WHO) – which initiated the South Africa hub to address regional inequity – is setting up a “biomanufacturing workforce training centre” to address the […] Continue reading -> Virus Reproduction Number in South Africa’s Omicron Epicentre is ‘Something We Have Never Seen’ 10/12/2021 Kerry Cullinan The virus reproduction number of the Omicron variant in Gauteng province – the epicentre of South Africa’s pandemic – is 3 – meaning that one infected person will infect three others on average. That is the highest seen so far in the country’s COVID-19 pandemic history – and testimony to the highly infectious nature of […] Continue reading -> World Health Assembly Appears Set to Move Ahead on Pandemic Treaty Negotiations – With Very Different Views About Outcomes 29/11/2021 Elaine Ruth Fletcher In a first face-to-face meeting in Geneva since the start of the COVID-19 pandemic, the World Health Organization’s 194 member states appeared set to adopt a landmark decision to negotiate a new treaty or framework convention governing pandemic response, dubbed “Our World Together”, and with over 100 countries now declaring co-sponsorship. But from the start […] Continue reading -> Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> ‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Independent Panel Co-Chairs Blast Slow Pace of Pandemic Reforms – Call for UN Summit After Next Week’s Special World Health Assembly 22/11/2021 Elaine Ruth Fletcher Six months after publication of their landmark report, Make it the Last Pandemic, the co-chairs of Independent Panel have re-entered the political fray over the slow pace of urgently needed reforms to vaccine equity, pandemic finance and countries’ legal obligations – that they say are required to end the COVID-19 pandemic and head off the […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> Posts navigation Older postsNewer posts
Virus Reproduction Number in South Africa’s Omicron Epicentre is ‘Something We Have Never Seen’ 10/12/2021 Kerry Cullinan The virus reproduction number of the Omicron variant in Gauteng province – the epicentre of South Africa’s pandemic – is 3 – meaning that one infected person will infect three others on average. That is the highest seen so far in the country’s COVID-19 pandemic history – and testimony to the highly infectious nature of […] Continue reading -> World Health Assembly Appears Set to Move Ahead on Pandemic Treaty Negotiations – With Very Different Views About Outcomes 29/11/2021 Elaine Ruth Fletcher In a first face-to-face meeting in Geneva since the start of the COVID-19 pandemic, the World Health Organization’s 194 member states appeared set to adopt a landmark decision to negotiate a new treaty or framework convention governing pandemic response, dubbed “Our World Together”, and with over 100 countries now declaring co-sponsorship. But from the start […] Continue reading -> Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> ‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Independent Panel Co-Chairs Blast Slow Pace of Pandemic Reforms – Call for UN Summit After Next Week’s Special World Health Assembly 22/11/2021 Elaine Ruth Fletcher Six months after publication of their landmark report, Make it the Last Pandemic, the co-chairs of Independent Panel have re-entered the political fray over the slow pace of urgently needed reforms to vaccine equity, pandemic finance and countries’ legal obligations – that they say are required to end the COVID-19 pandemic and head off the […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> Posts navigation Older postsNewer posts
World Health Assembly Appears Set to Move Ahead on Pandemic Treaty Negotiations – With Very Different Views About Outcomes 29/11/2021 Elaine Ruth Fletcher In a first face-to-face meeting in Geneva since the start of the COVID-19 pandemic, the World Health Organization’s 194 member states appeared set to adopt a landmark decision to negotiate a new treaty or framework convention governing pandemic response, dubbed “Our World Together”, and with over 100 countries now declaring co-sponsorship. But from the start […] Continue reading -> Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> ‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Independent Panel Co-Chairs Blast Slow Pace of Pandemic Reforms – Call for UN Summit After Next Week’s Special World Health Assembly 22/11/2021 Elaine Ruth Fletcher Six months after publication of their landmark report, Make it the Last Pandemic, the co-chairs of Independent Panel have re-entered the political fray over the slow pace of urgently needed reforms to vaccine equity, pandemic finance and countries’ legal obligations – that they say are required to end the COVID-19 pandemic and head off the […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> Posts navigation Older postsNewer posts
Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> ‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Independent Panel Co-Chairs Blast Slow Pace of Pandemic Reforms – Call for UN Summit After Next Week’s Special World Health Assembly 22/11/2021 Elaine Ruth Fletcher Six months after publication of their landmark report, Make it the Last Pandemic, the co-chairs of Independent Panel have re-entered the political fray over the slow pace of urgently needed reforms to vaccine equity, pandemic finance and countries’ legal obligations – that they say are required to end the COVID-19 pandemic and head off the […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> Posts navigation Older postsNewer posts
‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Independent Panel Co-Chairs Blast Slow Pace of Pandemic Reforms – Call for UN Summit After Next Week’s Special World Health Assembly 22/11/2021 Elaine Ruth Fletcher Six months after publication of their landmark report, Make it the Last Pandemic, the co-chairs of Independent Panel have re-entered the political fray over the slow pace of urgently needed reforms to vaccine equity, pandemic finance and countries’ legal obligations – that they say are required to end the COVID-19 pandemic and head off the […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> Posts navigation Older postsNewer posts
Independent Panel Co-Chairs Blast Slow Pace of Pandemic Reforms – Call for UN Summit After Next Week’s Special World Health Assembly 22/11/2021 Elaine Ruth Fletcher Six months after publication of their landmark report, Make it the Last Pandemic, the co-chairs of Independent Panel have re-entered the political fray over the slow pace of urgently needed reforms to vaccine equity, pandemic finance and countries’ legal obligations – that they say are required to end the COVID-19 pandemic and head off the […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> Posts navigation Older postsNewer posts
India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> Posts navigation Older postsNewer posts
WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> Posts navigation Older postsNewer posts